Lopinavir
Back to searchMolecule Structure
Scientific Name
Lopinavir
Description of the Drug
Lopinavir is an HIV-1 protease inhibitor used in combination with ritonavir to treat human immunodeficiency virus (HIV) infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01601
http://www.drugbank.ca/drugs/DB01601
Brand Name(s)
Kaletra
Company Owner(s)
Abbvie Inc, Laurus Labs Ltd, Hetero Labs Ltd Unit Iii, Lannett Co Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 protease | SINGLE PROTEIN | INHIBITOR | CHEMBL243 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL21775 | ||
| PharmGKB | PA450264 | ||
| Human Metabolome Database | HMDB0015539 | ||
| DrugBank | DB01601 | ||
| PubChem: Thomson Pharma | 14912305 | 14912304 | |
| PubChem | 92727 | ||
| LINCS | LSM-6027 | ||
| Nikkaji | J1.543.461I | ||
| PDBe | AB1 | ||
| BindingDB | 50180655 | 578 | |
| EPA CompTox Dashboard | DTXSID8046456 | ||
| DrugCentral | 1601 | ||
| Brenda | 229622 | 1430 | 229623 |
| rxnorm | KALETRA | LOPINAVIR | |
| PubChem: Drugs of the Future | 56310583 | ||
| KEGG Ligand | C12871 | ||
| ChEBI | 31781 | ||
| ZINC | ZINC000003951740 |
